<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) May 29, 1998
ALLERGAN, INC.
- -------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 1-10269 95-1622442
- -------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
2525 Dupont Drive, Irvine, California 92612
- -------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (714) 246-4500
N/A
- -------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
ITEM 5. OTHER EVENTS.
Tamara J. Erickson has resigned as a director of Allergan, Inc. to pursue other
interests, effective May 29, 1998. There were no disagreements with Allergan or
any matter relating to Allergan's operations, policies or practices.
-2-
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ALLERGAN, INC.
Date: June 5, 1998 By: /S/ FRANCIS R. TUNNEY, JR.
----------------------------
Francis R. Tunney, Jr.
Corporate Vice President,
General Counsel and Secretary
-3-
